Angiodynamics (ANGO) Finished Goods (2012 - 2014)

Angiodynamics has reported Finished Goods for 3 years, with the latest figure at $23.2 million in Q1 2014.

• For the quarter ending Q1 2014, Finished Goods changed N/A year-over-year to $23.2 million; the trailing twelve-month figure through Feb 2014 stood at $23.2 million (changed N/A YoY), and the FY2013 full-year result was $25.7 million, down 6.0% from the prior year.
• Finished Goods for Q1 2014 stood at $23.2 million, down from $24.2 million in the prior quarter.
• The five-year high for Finished Goods was $32.6 million in Q3 2012, with the low at $23.2 million in Q1 2014.
• Historically, Finished Goods has averaged $26.4 million across 3 years, with a median of $25.7 million in 2013.
• The largest YoY upside for Finished Goods was 6.0% in 2013 against a maximum downside of 21.3% in 2013.
• Angiodynamics' Finished Goods stood at $32.6 million in 2012, then decreased by 25.63% to $24.2 million in 2013, then fell by 4.32% to $23.2 million in 2014.
• The last three Finished Goods figures came in at $23.2 million (Q1 2014), $24.2 million (Q4 2013), and $25.6 million (Q3 2013), per Business Quant data.